Investors / United States / GV
GV
Venture capital · Mountain View, CA, United States · North America
GV is an independent venture capital firm with Alphabet as its sole limited partner. It invests in technology and life sciences companies and supports founding teams with operating partners in executive talent, communications, and marketing, and connects startups with Google and Alphabet.
Invests inHealthcare & BiotechAI & Machine Learning
In its own wordsailife scienceshealthcareenterprisedeveloper toolssecurity
Your fit with GV
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsGV lists 117 checked portfolio companies on its own site and is named in 136 funding rounds, 41 of them as lead. Its most frequent entry is Growth, 32% of the companies with a known first round. Its largest themes are Healthcare & Biotech (28%), AI & Machine Learning (24%) and Enterprise Software (9%). 79% of its companies are based in United States. It invests most often alongside Andreessen Horowitz, General Catalyst and Sequoia Capital.
Counts come from funding rounds that name GV, complete from mid-2025: earlier rounds appear only when they were reported later. Round amounts and full round histories are on Fundup AI.
Entry stage
share of companies by the stage of its first roundShow as a table
| Value | |
|---|---|
| Pre-seed | 0% |
| Seed | 13% |
| Series A | 31% |
| Series B | 24% |
| Growth | 32% |
Activity by year
rounds it joined, last 10 yearsShow as a table
| Total | Rounds it led | |
|---|---|---|
| '17 | 0 | 0 |
| '18 | 0 | 0 |
| '19 | 1 | 0 |
| '20 | 1 | 0 |
| '21 | 2 | 0 |
| '22 | 4 | 0 |
| '23 | 4 | 1 |
| '24 | 10 | 3 |
| '25 | 51 | 19 |
| '26 | 61 | 18 |
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 97th | 117 companies |
| Recent activity | 100th | 63 rounds in 12 months |
| Early stage | 55th | 13% of entries at pre-seed or seed |
| Evidence | 52th | 0% of companies confirmed by a round |
| Sector focus | 44th | 28% in its largest sector |
| Reach | 97th | 12 countries |
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 28% | 15% |
| AI & Machine Learning | 24% | 18% |
| Enterprise Software | 9% | 8% |
| Cybersecurity | 7% | 4% |
| Fintech | 7% | 12% |
| Education | 6% | 7% |
| Space & Defense | 5% | 3% |
| Industrial & Manufacturing | 5% | 7% |
Invests most often with
firms sharing its portfolio companiesShow as a table
| Share | |
|---|---|
| Andreessen Horowitz | 25 |
| General Catalyst | 16 |
| Sequoia Capital | 14 |
| Lightspeed Venture Partners | 13 |
| Accel | 12 |
| Khosla Ventures | 10 |
| ARCH Venture Partners | 9 |
| Casdin Capital | 8 |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers11598%
- No longer answers00%
- Points to another company22%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Co-investor network
who it backs companies with, and who they back togetherAll co-investors or Compare portfolios with Andreessen Horowitz
Compare GV head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Recent portfolio activity
when companies last raised with GV| Date | Company | Stage |
|---|---|---|
| 12 Nov 2026 | Series A Led | |
| 12 Nov 2026 | Series A | |
| 11 Nov 2026 | Series B | |
| 10 Nov 2026 | Series A | |
| 21 Oct 2026 | Series C+ | |
| 21 Oct 2026 | Series A | |
| 16 Oct 2026 | Series A | |
| 15 Oct 2026 | Series C+ |
Round details for GV
Amounts, full round histories and every co-investor in GV's rounds are on Fundup AI. VCinfo covers investors and their portfolios.
Portfolio
117 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| Abridge develops and provides generative AI for clinical conversations and documentation in healthcare. | Healthcare & BiotechAI & Machine Learning | Oct 2025Series C+ | Funding round | |
| Adapter provides a cognition API for AI agents and apps | AI & Machine LearningSpace & Defense | Jul 2026Series A | Funding round | |
| Affinia Therapeutics develops gene therapies, specifically adeno-associated virus (AAV) gene therapy, for diseases such as BAG3-associated dilated cardiomyopathy | Healthcare & Biotech | Oct 2025Series C+ | Funding round | |
| AI21 trains specialized models for clients using their data to create customized AI solutions | AI & Machine LearningEnterprise Software | May 2025Series C+ | Funding round | |
| Allara Health provides virtual women's health services, including personalized treatment plans and ongoing support, covered by insurance or available through self-pay options. | Healthcare & Biotech | Oct 2026Series B | Funding round | |
| Alta provides a universal tokenized infrastructure for institutions, offering various financial services such as cross-border payments, embedded finance, and treasury management. | FintechFintech | Nov 2026Series A | Funding round | |
| Anthropic develops AI models and products, including the Claude models, and conducts AI safety research. | AI & Machine LearningEnterprise Software | Apr 2026Series C+ | Funding round | |
| AppsFlyer provides a range of products and services for marketing measurement, attribution, and analytics across various platforms | Media & EntertainmentE-commerce & Marketplaces | Jun 2026Series C+ | Funding round | |
| Apptronik provides solutions for businesses, including goods-to-person, person-to-goods, packout, kitting, inspection and sorting, and machine and tool tending. | Industrial & Manufacturing | Mar 2025Series A · 2 rounds | Funding round | |
| Arboretum partners with healthcare systems to implement genetic testing programs for various diseases | Healthcare & Biotech | Oct 2026Series A | Funding round | |
| Arda Therapeutics is taking aim at chronic diseases by eliminating the pathogenic cells that drive them. | Healthcare & Biotech | Oct 2024Series A | Funding round | |
| Mar 2026Series A · 2 rounds | Funding round | |||
| Attio provides a customer relationship management platform for revenue teams | AI & Machine LearningEnterprise Software | Aug 2025Series B | Funding round | |
| Beacon Biosignals uses AI-powered technology to accelerate drug development and power home sleep testing diagnostics | Healthcare & Biotech | Nov 2025Series B | Funding round | |
| Blacksmith provides a faster and more cost-efficient way to run GitHub Actions for software development teams | Developer ToolsCybersecurity | May 2025Seed · 4 rounds | Funding round | |
| Blockaid provides security services to prevent scams, fraud, and compliance risks for companies operating on blockchain finance. | FintechCybersecurity | Feb 2025Series B | Funding round | |
| The company builds autonomous ships for the open ocean | AI & Machine LearningAI & Machine Learning | Aug 2025Series A | Funding round | |
| Carry1st publishes and distributes mobile games in Africa and the Middle East. | GamingEnterprise Software | Jan 2022Series A | Funding round | |
| Censys provides internet intelligence and insights for security operations and exposure management. | Cybersecurity | Mar 2026Series C+ | Funding round | |
| Cerevance develops therapies for neurodegenerative disorders, including Parkinson's disease. | Healthcare & Biotech | May 2026Series C+ | Funding round |
About this data
site last read 5 Nov 2026- Site
- gv.com
- Last read
- 5 Nov 2026
- Watching since
- 5 Nov 2026
- Rounds since
- 19 Jul 2012
- Companies checked
- 117
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get GV's profile as data
Pull GV's portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/gv.com
# also
GET /v1/firms/gv.com/portfolio
GET /v1/firms/gv.com/coinvestors
GET /v1/firms/gv.com/news